Biomind Labs (NEOE:BMND) Pre-Tax Income : C$-1.97 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Biomind Labs's pretax income for the three months ended in Sep. 2023 was C$-0.17 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.97 Mil. Biomind Labs's pretax margin was %.

Biomind Labs Pre-Tax Income Historical Data

The historical data trend for Biomind Labs's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Pre-Tax Income Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Pre-Tax Income

-5.55

-4.06

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Pre-Tax Income	Get a 7-Day Free Trial						-1.23	-0.72	-0.59	-0.48	-0.17

Competitive Comparison of Biomind Labs's Pre-Tax Income

For the Biotechnology subindustry, Biomind Labs's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomind Labs's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Pre-Tax Income falls into.

Biomind Labs Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Biomind Labs's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.987	+	-0.067	+	-0.001	+	0	+	-0.0010000000000003
	=	-4.06

Biomind Labs's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.175	+	0.004	+	0	+	0	+	0.00099999999999997
	=	-0.17

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.97 Mil.

Biomind Labs (NEOE:BMND) Pre-Tax Income Explanation

Biomind Labs's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.17	/	0
	=	%

Biomind Labs Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomind Labs (NEOE:BMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

3XI:Germany

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines